US Patent Issued to YOUCARE PHARMACEUTICAL GROUP on Dec. 9 for "Method for optimizing virus membrane fusion inhibitor, broad-spectrum anti-coronavirus lipopeptide and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,266, issued on Dec. 9, was assigned to YOUCARE PHARMACEUTICAL GROUP Co. LTD. (Beijing).

"Method for optimizing virus membrane fusion inhibitor, broad-spectrum anti-coronavirus lipopeptide and use thereof" was invented by Yuxian He (Beijing), Yuanmei Zhu (Beijing), Huihui Chong (Beijing) and Nian Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method for optimizing a virus membrane fusion inhibitor, a broad-spectrum anti-coronavirus lipopeptide and use thereof. The present disclosure provides compounds or pharmaceutically acceptable salts thereof or derivatives thereof, wherein the compounds are shown in...